Skip to content

Legal status · Australia

Is Apelin legal in Australia?

Written by Reviewed Sep 2026

Not approvedMetabolicHuman studies cited: 6

Direct answer

No. Apelin is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile.

Apelin in Australia at a glance

ClassificationNot approved
NoteNo TGA-registered product.
TGA approval statusNot approved by TGA
Human studies cited6 of 10 citations on the profile
ReviewedSep 2026

Classification and note come from the Apelin profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

  • 01

    No product containing Apelin is approved by TGA for any use in Australia, so nothing on the market is authorized for people.

  • 02

    "Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.

  • 03

    Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.

What Apelin is

A vasodilator and cardiac inotrope in humans, shown by infusion in about 50 people including 18 with heart failure, where its effect was preserved when acetylcholine's was not. The sarcopenia-reversal claim is mouse work; three completed human studies of apelin and insulin sensitivity or cardiovascular effects have never posted results.

Apelin is a family of peptides cut from a 77 amino acid precursor: apelin-36, apelin-31, apelin-28 and apelin-13, with pyroglutamated apelin-13 usually reported as the dominant circulating form. All of them activate the APJ receptor, a class A G protein-coupled receptor also targeted by a second, unrelated ligand called ELABELA.

Mechanism: Established in humans by infusion: apelin peptides cause arterial vasodilatation that depends on nitric oxide (abolished by a nitric oxide clamp, unaffected by aspirin), have no effect on venous tone, increase coronary blood flow and left ventricular contractility, and raise cardiac output while lowering blood pressure and peripheral resistance, in healthy people and in heart failure alike. Established in mice: apelin is induced by muscle contraction, declines with age, and its absence or its receptor's absence produces marked age-related muscle deterioration; restoring it improves muscle function through mitochondrial biogenesis, autophagy, anti-inflammatory signalling and muscle stem cell effects.

Regulatory history: Not FDA-approved. No apelin peptide or APJ receptor agonist is approved anywhere. Novartis's APJ agonist CLR325 completed a 26-patient phase 2 safety study in heart failure in 2019; native apelin has been given to people only in acute physiology studies.

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Apelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Apelin in other countries

Frequently asked questions

Is Apelin legal in Australia?

No. Apelin is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile. Note: No TGA-registered product.

Can I buy Apelin in Australia?

No approved product exists to buy. In Australia Apelin is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No TGA-registered product.

Is Apelin TGA approved?

No. In Australia Apelin is classified as "Not approved", which is not a TGA marketing approval. For comparison, the US FDA status is: Not FDA-approved. No apelin peptide or APJ receptor agonist is approved anywhere. Novartis's APJ agonist CLR325 completed a 26-patient phase 2 safety study in heart failure in 2019; native apelin has been given to people only in acute physiology studies.. On the evidence, 6 human studies are cited on its profile.

Related compounds in Australia

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Apelin live on its compound profile.

Apelin profile

This page is general information about the regulatory status of Apelin in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.